| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.2M | — | +24.0% |
| Cost of Revenue | $977K | — | +3.3% |
| Gross Profit | $2.2M | — | +36.0% |
| R&D Expense | $123K | — | -20.6% |
| SG&A Expense | $1.7M | — | -23.8% |
| Operating Income | -$1.5M | — | +36.3% |
| Pre-tax Income | -$1.5M | — | +33.8% |
| Net Income | -$1.5M | — | +33.8% |
| EPS (Basic) | -$1.68 | — | -1300.0% |
| EPS (Diluted) | -$1.68 | — | -1300.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.1M | -40.9% | -76.6% |
| Short-term Investments | $5.4M | -8.5% | — |
| Accounts Receivable | $6K | +9.8% | -97.3% |
| Inventory | $1.8M | +31.5% | +167.0% |
| Current Assets | $10.0M | -13.5% | -39.2% |
| Total Assets | $18.5M | -8.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.6M | — | +0.3% |
| Capital Expenditures | $27K | — | — |
| Investing Cash Flow | $264K | — | +104.3% |
| Financing Cash Flow | -$75K | — | -100.6% |
| Free Cash Flow | -$1.7M | — | — |
| -26.6% |
| Current Liabilities | $1.6M | -17.6% | -27.0% |
| Total Liabilities | $1.9M | -16.0% | -15.5% |
| Stockholders' Equity | $14.8M | -8.9% | -30.0% |